FORA Capital, LLC
"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.
13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.
We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 24 quarters, returned +4.0% per quarter — versus +3.9% per quarter from simply owning every 13F stock. It beat that baseline in only 50.0% of quarters (excess t = -0.13, not statistically significant). Its filings tell you what it bought — not what you should buy.
Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)
Top 20 holdings of 413 · 2026 Q1
| Ticker | Value | Weight | QoQ |
|---|---|---|---|
| BSX | $23M | | ADD |
| ORCL | $23M | | ADD |
| SOFI | $23M | | ADD |
| XOM | $23M | | ADD |
| GOOGL | $23M | | ADD |
| MSFT | $23M | | ADD |
| B | $23M | | NEW |
| VZ | $22M | | ADD |
| LMT | $21M | | ADD |
| FISV | $21M | | ADD |
| CAT | $20M | | ADD |
| V | $18M | | ADD |
| NEM | $17M | | NEW |
| GM | $17M | | ADD |
| CMI | $16M | | ADD |
| RBLX | $16M | | ADD |
| TEL | $16M | | ADD |
| PBR | $15M | | NEW |
| WBD | $15M | | ADD |
| ASML | $15M | | NEW |
QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.
New positions in 2026 Q1
Method & Limitations
Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.